Long -Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once -Daily Tacrolimus

被引：0
|
作者：
Gastaca, Mikel [1 ,3 ]
Prieto, Mikel [1 ,3 ]
Palomares, Ibone [1 ]
Bustamante, Javier [2 ]
Fernandez, Jose R. [2 ]
Ruiz, Patricia [1 ]
Ventoso, Alberto [1 ]
Salvador, Patricia [2 ]
Senosiain, Maria [2 ]
Testillano, Milagros [2 ]
Suarez, Maria J. [2 ]
Valdivieso, Andres [1 ,3 ]
机构：
[1] Hosp Univ Cruces, Biocruces Bizkaia Hlth Res Inst, Hepatobiliary Surg & Liver Transplantat Unit, Bilbao, Spain
[2] Hosp Univ Cruces, Biocruces Bizkaia Hlth Res Inst, Hepatol Unit, Bilbao, Spain
[3] Univ Basque Country, Med Dept, Bilbao, Spain
来源：
TRANSPLANTATION PROCEEDINGS | 2020年 / 52卷 / 05期
关键词：
KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; RECIPIENTS; MONOTHERAPY; IMMUNOSUPPRESSION; MORTALITY; EFFICACY; FAILURE; DISEASE;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1489 / 1492
页数：4
相关论文
共 50 条
  • [31] SHORT AND LONG-TERM OUTCOMES OF SWITCH INTO ONCE-DAILY EXTENDED RELEASE TACROLIMUS FROM IMMEDIATE-RELEASE TACROLIMUS TWICE DAILY IN LIVER TRANSPLANT RECIPIENTS
    Del Gaudio, Massimo
    Maroni, Lorenzo
    Bertuzzo, Valentina
    Zanfi, Chiara
    Serenari, Matteo
    Ravaioli, Matteo
    Rossetto, Anna
    Odaldi, Federica
    Frascaroli, Giacomo
    Morelli, Maria Cristina
    Siniscalchi, Antonio
    Cescon, Matteo
    TRANSPLANT INTERNATIONAL, 2019, 32 : 374 - 375
  • [32] Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: A single-center experience with 394 patients
    Dumortier, Jerome
    Guillaud, Olivier
    Boillot, Olivier
    LIVER TRANSPLANTATION, 2013, 19 (05) : 529 - 533
  • [33] Poor long term outcome of patients undergoing liver transplantation with preterminal renal dysfunction
    Touma, Marcel
    Horvatits, Thomas
    Pischke, Sven
    Fischer, L.
    Lohse, Ansgar W.
    Sterneck, Martina
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E570 - E571
  • [34] Sequential Cohort Analysis After Liver Transplantation Shows de Novo Extended Release Tacrolimus Is Safe, Efficacious, and Minimizes Renal Dysfunction
    Lim, Tiong Yeng
    McPhail, Mark J.
    Shah, Amar
    Mahgoub, Sara
    Nayagam, Jeremy
    Cramp, Matthew
    Bernal, William
    Menon, Krish
    Jassem, Wayel
    Joshi, Deepak
    Heneghan, Michael A.
    Agarwal, Kosh
    Heaton, Nigel D.
    Suddle, Abid
    O'Grady, John G.
    Aluvihare, Varuna R.
    TRANSPLANTATION DIRECT, 2020, 6 (02): : E528
  • [35] Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial
    Okumi, Masayoshi
    Unagami, Kohei
    Furusawa, Miyuki
    Kakuta, Yoichi
    IIzuka, Junpei
    Takagi, Toshio
    Shirakawa, Hiroki
    Shimizu, Tomokazu
    Omoto, Kazuya
    Inui, Masashi
    Ishida, Hideki
    Tanabe, Kazunari
    CLINICAL TRANSPLANTATION, 2018, 32 (12)
  • [36] LONG-TERM OUTCOMES OF RENAL TRANSPLANT RECIPIENTS TREATED WITH IVIG FOR DE NOVO DONOR SPECIFIC ANTIBODIES
    Knight, Richard J.
    Khan, Naja A.
    Nguyen, Duc T.
    Graviss, Edward A.
    Eagar, Todd N.
    Gaber, Osama
    TRANSPLANTATION, 2020, 104 (09) : S364 - S364
  • [37] EFFECT OF CONVERSION TO LONG ACTING TACROLIMUS ON RENAL FUNCTION IN LONG-TERM-FOLLOWED PATIENTS AFTER LIVER TRANSPLANTATION
    Egawa, Hiroto
    Yamashina, Sachi
    Kogiso, Tomomi
    Nemoto, Satoshi
    Yamashita, Shingo
    Ohmori, Akiko
    Kotera, Yuto
    Yamamoto, Masakazu
    TRANSPLANT INTERNATIONAL, 2017, 30 : 471 - 472
  • [38] Long term renal outcome of patients requiring de novo renal replacement therapy after cardiac surgery
    Hu, Jiayi
    Sanchez, Itzel V.
    Wagener, Gebhard
    ANESTHESIA AND ANALGESIA, 2022, 134 : 235 - 236
  • [39] Long-Term Outcomes of Patients Treated With Tacrolimus as First Line Therapy for Minimal Change Disease
    Seneschall, Charlotte
    Dattani, Rakesh
    Cairns, Tom
    McAdoo, Stephen P.
    Medjeral-Thomas, Nicholas R.
    Griffith, Megan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 503 - 503
  • [40] POOLED ANALYSIS TO EXAMINE THE PK AND SAFETY OF ONCE-DAILY EXTENDED-RELEASE MELTDOSE® TACROLIMUS TABLETS (ENVARSUS®) VS. TWICE-DAILY TACROLIMUS (PROGRAF®) IN DE NOVO KIDNEY AND LIVER TRANSPLANTATION
    Mulgaonkar, Shamkant
    Dubay, Derek
    Bunnapradist, Suphamai
    TRANSPLANT INTERNATIONAL, 2015, 28 : 202 - 202
12345